Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alcon, Inc.
Alcon Files Form 20-F with U.S. Securities and Exchange Commission
April 6th, 2008
Alcon, Inc. (NYSE:ACL) has filed its Form 20-F annual report of foreign private issuer with the U.S. Securities and Exchange Commission (SEC). An electronic version of this annual filing is available for review in the Investors and Media section of the company's web site at www.alcon.com or in the SEC's EDGAR database at www.sec.gov. Investors may obtain a printed copy of Alcon's audited financial statements free of charge by contacting Alcon Investor Relations either by phone or in writing at the address below. -0- *T Keywords: Alcon, Inc. This article was prepared by Pharma Investments, Ventures & Law Week editors from staff and...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
